<DOC>
<DOCNO>
EP-0001193
</DOCNO>
<TEXT>
<DATE>
19790321
</DATE>
<IPC-CLASSIFICATIONS>
C07D-235/00 A61K-31/185 <main>C07C-149/26</main> C07D-235/02 C07C-101/36 C07D-333/00 C07D-333/34 A61K-31/195 C07C-45/63 C07C-45/00 
</IPC-CLASSIFICATIONS>
<TITLE>
carbocylic amino acids, methods for their preparation and pharmaceutical compositions containing them.
</TITLE>
<APPLICANT>
science union & cie fr <sep>science union et cie societe francaise de recherche medicale<sep>science union et cie societe francaise de recherche medicale14 rue du val d'orf-92150 suresnesfr<sep>science union et cie societe francaise de recherche medicale<sep>
</APPLICANT>
<INVENTOR>
bure jacques<sep>remond georges<sep>vincent michel<sep>bure jacques<sep>remond, georges<sep>vincent, michel<sep>bure jacques22 rue perronet92200 neuilly sur seinefr<sep>remond, georges9 avenue des etats unis78800 versaillesfr<sep>vincent, michel8, allée du prunier hardyf-92220 bagneuxfr<sep>bure jacques  <sep>remond, georges<sep>vincent, michel<sep>bure jacques22 rue perronet92200 neuilly sur seinefr<sep>remond, georges9 avenue des etats unis78800 versaillesfr<sep>vincent, michel8, allée du prunier hardyf-92220 bagneuxfr<sep>
</INVENTOR>
<ABSTRACT>
The object of the invention relates to the cyclic acid amino of the general formula I in which R is hydrogen or a lower alkyl radical. R 'is hydrogen, a lower alkyl radical, a lower alkyl radical whose alkyl chain is substituted with one or two hydroxyls, lower acyloxy, lower alkoxy, lower alkylamino, lower dialkoylamino, an aryl radical, a phenyl lower alkyl radical whose benzenic core is substituted or unsubstituted, a benzhydryl radical, or a tiphenylmehyl radical. x is a hydroxy, a lower alkoxy, a lower alkoxy whose alkyl channel is mono or disubstituted, a hydroxy amino radical, an amino radical or an alkylamino radical and n is zero or an integer varying from 1 to 3. L The invention also relates to the salts of the compounds of general formula I with a mineral or organic acid or a mineral or organic base, preferably therapeutically compatible. The invention also relates to Erythro and Threo diastereoisomers of compounds of general formula I as well as the optical isomers of these compounds. The invention also relates to the pharmaceutical compositions containing as an active ingredient at least one compound of formula I or one of its addition salts, in combination with an excipient or a pharmaceutical vehicle. The compounds according to the invention are characterized by interesting pharmacological properties especially as immuno-de-presses and as a soluble collagen protector.
</ABSTRACT>
</TEXT>
</DOC>
